Prescription opioid exposures among children and adolescents in the United States: 2000-2015

Pediatrics

Volumn 139, Issue 4, 2017, Pages

  Allen, Jakob D ^a   Casavant, Marcel J ^a,b,c   Spiller, Henry A ^b,c   Chounthirath, Thiphalak ^a   Hodges, Nichole L ^a   Smith, Gary A ^a,c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b Central Ohio Poison Center   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; HYDROCODONE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADOLESCENCE; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AUTOMUTILATION; CHILD; CHILD HOSPITALIZATION; CHILDHOOD; CONTROLLED STUDY; DRUG EXPOSURE; DRUG INTOXICATION; FEMALE; HIGH RISK BEHAVIOR; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POISON CENTER; REVIEW; RISK ASSESSMENT; SUICIDE; TREND STUDY; UNITED STATES; DRUG MISUSE; FACTUAL DATABASE; OPIOID-RELATED DISORDERS; PRESCHOOL CHILD; PRESCRIPTION; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ANALGESICS, OPIOID; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; MALE; OPIOID-RELATED DISORDERS; POISON CONTROL CENTERS; PRESCRIPTION DRUG MISUSE; PRESCRIPTIONS; UNITED STATES; YOUNG ADULT;

EID: 85018953152     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-3382     Document Type: Review

References (48)

1. Daubresse M, Chang HY, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013;51(10):870-878
2. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. MMWR Recomm Rep. 2016;65(1): 1-49
3. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(2 suppl):S63-S88
4. Follin SL, Charland SL. Acute pain management: operative or medical procedures and trauma. Ann Pharmacother. 1997;31(9):1068-1076
5. Tadros A, Layman SM, Davis SM, Bozeman R, Davidov DM. Emergency department visits by pediatric patients for poisoning by prescription opioids. Am J Drug Alcohol Abuse. 2016;42(5):550-555
6. Gaither JR, Leventhal JM, Ryan SA, Camenga DR. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatr. 2016;170(12):1195-1201
7. Sachdeva DK, Stadnyk JM. Are one or two dangerous? Opioid exposure in toddlers. J Emerg Med. 2005;29(1):77-84
8. Tobias JD, Green TP, Cote CJ; Section on Anesthesiology and Pain Medicine; Committee on Drugs. Codeine: time to say "no". Pediatrics. 2016;138(4):e20162396
9. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50-51):1378-1382
10. Centers for Disease Control and Prevention; National Center for Health Statistics. National Vital Statistics System, Mortality File. Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States, 2000-2014. Center for Disease Control and Prevention; 2015. Available at: www.cdc.gov/nchs/data/health-policy/AADR-drug-poisoning-involving-OA-Heroin-US-2000-2014.pdf. Accessed October 3, 2016
11. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492
12. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62(26):537-542
13. Centers for Disease Control and Prevention. 10 Leading causes of injury deaths by age group highlighting unintentional injury deaths, United States-2014. Available at: www.cdc.gov/injury/wisqars/leadingcauses.html. Accessed October 3, 2016
14. Centers for Disease Control and Prevention. Vital signs: unintentional injury deaths among persons aged 0-19 years-United States, 2000-2009. MMWR Morb Mortal Wkly Rep. 2012;61:270-276
15. McCabe SE, West BT, Teter CJ, Boyd CJ. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med. 2012;166(9):797-802
16. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2):95-100
17. Muhuri PK, Gfroerer JC, Davies MC. CBHSQ data review: associations of nonmedical pain reliever use and initiation of heroin use in the United States. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; August 2013. Available at: www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedicalpain-reliever-use-2013.htm. Accessed October 3, 2016
18. Mahic M, Fredheim OM, Borchgrevink PC, Skurtveit S. Use of prescribed opioids by children and adolescents: differences between Denmark, Norway and Sweden. Eur J Pain. 2015;19(8):1095-1100
19. Volkow ND. Prescription opioid and heroin abuse. 2014. Available at: https://www.drugabuse.gov/aboutnida/legislative-activities/testimonyto-congress/2015/prescription-opioidheroin-abuse. Accessed October 3, 2016
20. Qin A, Layton A. Unintentional pediatric poisoning injury estimates for 2014. Bethesda, MD: Consumer Product Safety Commission; 2015. Available at: https://www.cpsc.gov/s3fs-public/PPPAInjury2014.pdf. Accessed October 3, 2016
21. Qin A. Pediatric poisoning fatalities from 1972 through 2013. Bethesda, MD: US Consumer Product Safety Commission; 2016. Available at: https://www.cpsc.gov/s3fs-public/PPPAMortality2013.pdf. Accessed October 3, 2016
22. Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd annual report. Clin Toxicol (Phila). 2015;53(10):962-1147
23. National Poison Data System. NPDS coding users' manual version 3.1. American Association of Poison Control Centers; 2014. Available at: http://aapcc. s3. amazonaws.com/pdfs/member-resources/NPDS-Coding-Users-Manual-v3. 1-07May2014.pdf. Accessed October 3, 2016
24. US Census Bureau. US-EST00INTALLDATA: intercensal estimates of the resident population by single year of age, sex, race and hispanic origin for the United States: April 1, 2000 to July 1, 2010. 2012. Available at: www.census.gov/popest/data/intercensal/national/nat2010.html. Accessed October 3, 2016
25. US Census Bureau. PEPSYASEXN: annual estimates of the resident population by single year of age and sex for the United States: April 1, 2010 to July 1, 2015. 2016. Available at: http://factfinder. census.gov/faces/tableservices/jsf/pages/productview. xhtml? pid= PEP-2015-PEPSYASEXN& prodType= table. Accessed October 3, 2016
26. The Express Scripts Lab. A nation in pain: focusing on U.S. opioid trends for treatment of short-term and longerterm pain. Express Scripts Holding Company; 2014. Available at: http://lab. express-scripts.com/lab/publications/a-nation-in-pain. Accessed October 3, 2016
27. Drug Enforcement Administration, Department of Justice. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II: final rule. Fed Regist. 2014;79(163):49661-49682
28. Jones CM, Lurie PG, Throckmorton DC. Effect of US Drug Enforcement Administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing. JAMA Intern Med. 2016;176(3):399-402
29. PROTECT Initiative. Advancing children's medication safety. Centers for Disease Control and Prevention; 2010. Available at: www.cdc.gov/medicationsafety/protect/protect-initiative.html. Accessed October 3, 2016
30. Tulve NS, Suggs JC, McCurdy T, Cohen Hubal EA, Moya J. Frequency of mouthing behavior in young children. J Expo Anal Environ Epidemiol. 2002;12(4):259-264
31. Denning DG, Conwell Y, King D, Cox C. Method choice, intent, and gender in completed suicide. Suicide Life Threat Behav. 2000;30(3):282-288
32. Suicide.org. Suicide statistics. 2005. Available at: www.suicide.org/suicidestatistics.html#death-rates. Accessed October 3, 2016
33. Steinberg L. Risk taking in adolescence-new perspectives from brain and behavioral science. Curr Dir Psychol Sci. 2007;16(2):55-59
34. Saxon AJ, Hser YI, Woody G, Ling W. Medication-assisted treatment for opioid addiction: methadone and buprenorphine. J Food Drug Anal. 2013;21(4):S69-S72
35. Gibson EJ. Exploratory behavior in the development of perceiving, acting, and the acquiring of knowledge. Annu Rev Psychol. 1988;39(1):1-41
36. Pedapati EV, Bateman ST. Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone. Pediatr Crit Care Med. 2011;12(2):e102-e107
37. Tenenbein M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med. 2005;159(6):557-560
38. Institute for Safe Medication Practices. Simple packaging change can reduce Rx drug diversion. 2014. Available at: www.consumermedsafety.org/medication-safety-articles/item/721-simple-packaging-change-can-reducerx-drug-diversion. Accessed October 3, 2016
39. PROTECT Initiative. Up and away and out of sight. 2014. Available at: http://upandaway.org/. Accessed October 3, 2016
40. Sontag D. Addiction treatment with a dark side. New York Times. November 17, 2013. Available at: www.nytimes.com/2013/11/17/health/in-demand-inclinics-and-on-the-street-bupe-can-besavior-or-menace.html?-r=0. Accessed October 3, 2016
41. Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav. 2010;35(11):1001-1007
42. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Marijuana use continues to rise among U.S. teens, while alcohol use hits historic lows [press release]. Ann Arbor, MI: University of Michigan News Service; 2011. Available at: www.monitoringthefutu re.org/pressreleases/11drugpr-complete.pdf. Accessed October 3, 2016
43. National Institute on Drug Abuse. White House Drug Policy Office and National Institute on Drug Abuse unveil new training materials to combat national prescription drug abuse epidemic. 2012. Available at: https://www.drugabuse.gov/news-events/news-releases/2012/white-house-drugpolicy-office-national-institute-drugabuse-unveil-new-training-materials-tocombat. Accessed October 3, 2016
44. National Center for Injury Prevention and Control. From Epi to policy: prescription drug overdose. Centers for Disease Control and Prevention; 2013. Available at: https://www.cdc.gov/drugoverdose/pdf/pdo-epi-to-policy-meeting-a.pdf. Accessed October 3, 2016
45. Wheeler E, Jones TS, Gilbert MK, Davidson PJ; Centers for Disease Control and Prevention. Opioid overdose prevention programs providing naloxone to laypersons-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631-635
46. Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989
47. Robertson EB, David SL, Rao SA, National Institute on Drug Abuse. Preventing Drug Use Among Children and Adolescents: A Research-Based Guide for Parents, Educators, and Community Leaders. 2nd ed. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; 2003
48. Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893